Dr. Lorky Nercessian Libaridian, MD

Dr. Libaridian practices at CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance.

Dr. Libaridian's NPI, 1497767958, was assigned on August 13, 2006. Dr. Libaridian graduated from Yale School of Medicine in 2005. Dr. Libaridian holds Massachusetts license 257015.

Dr. Libaridian's primary practice is CHA Cambridge Hospital, at 1493 Cambridge Street, Cambridge, MA 02139 in Middlesex County. The practice phone is (617) 665-1000.

Dr. Libaridian's primary practice is CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance. The medical group on file is Cambridge Health Alliance. Dr. Libaridian's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Libaridian practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Libaridian's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Libaridian is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Libaridian's licenses on file in 4 states: Massachusetts, California, New Hampshire and New York.

Dmand AI lists chronic anemia, chronic hypertension, chronic kidney disease and head injury among the conditions Dr. Libaridian treats.

CMS data shows 27 Medicare services from Dr. Libaridian across 1 procedure code in 2022, all of them office visits, for 16 Medicare patients. Medicare paid $1,447 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 16 Medicare patients who saw Dr. Libaridian in 2024. 75% of them have high blood pressure. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Libaridian's median patient age at 44, with 61% women.

In 2024, Dr. Libaridian wrote 153 Medicare Part D claims for 47 patients. 86% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $199 in total drug cost. In 2023, CMS named 114 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Libaridian for performance year 2024, reported as part of a group. Dr. Libaridian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Libaridian, published from 2017 to 2024. 2022 was the busiest year, with 2. The most frequent topics are Armenia, Primary Health Care and Qualitative Research. Dr. Libaridian's most frequent co-authors are Aline Ara Baghdassarian, MD, Evangelos Messaris, MD, PhD and Heidi Johanna Rayala, MD, PhD.

Dr. Libaridian graduated from Yale School of Medicine in 2005.

Dr. Libaridian is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.